Cataract News and Research RSS Feed - Cataract News and Research

A cataract is a clouding of the lens in the eye that affects vision. Most cataracts are related to aging. Cataracts are very common in older people. By age 80, more than half of all Americans either have a cataract or have had cataract surgery.

A cataract can occur in either or both eyes. It cannot spread from one eye to the other.
Researchers create high-precision software for better detection of eye sensitivity

Researchers create high-precision software for better detection of eye sensitivity

Researchers at the University of Alicante have developed high-precision software for diagnosing eye sensitivity. This is a new technology that allows to quantify the degree of opacity in the posterior capsule of the eye caused by the growth of cells in the intraocular lens. [More]
Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

Phase 3 VIVID-DME trial of EYLEA Injection for treatment of DME shows improvement in visual acuity

Regeneron Pharmaceuticals, Inc. today announced that in the Phase 3 VIVID-DME trial of EYLEA® (aflibercept) Injection for the treatment of diabetic macular edema (DME), EYLEA 2 milligrams (mg) dosed monthly (2Q4) and EYLEA 2 mg dosed every two months (after 5 initial monthly injections, 2Q8) showed a sustained improvement from baseline in best corrected visual acuity (BCVA) at week 100 (2 years), compared to laser photocoagulation. [More]
Cataract surgery for people with dementia slows cognition decline, improves quality of life

Cataract surgery for people with dementia slows cognition decline, improves quality of life

Cataract surgery for people with Alzheimer's disease and other dementias not only improves vision but can slow decline in cognition and improve quality of life for both people with the disease and their caregivers, according to clinical trial results reported today at the Alzheimer's Association International Conference 2014 (AAIC 2014) in Copenhagen. [More]
Quantel Medical receives FDA clearance for Optimis Fusion integrated laser platform

Quantel Medical receives FDA clearance for Optimis Fusion integrated laser platform

Quantel Medical today announced FDA 510(k) clearance for its Optimis Fusion integrated laser platform. The Optimis Fusion system combines advanced selective laser trabeculoplasty (SLT) photoregeneration therapy and traditional YAG photodisruption treatments to offer ophthalmologists a versatile armamentarium for treating both cataract and glaucoma in an efficient combination platform. [More]
Vitreous anatomic features characterised

Vitreous anatomic features characterised

Researchers have found a direct anteroposterior connection between the retrolental and premacular and preoptic spaces that exits in young adults before the occurrence of vitreous degeneration. [More]
Researchers find unique cell type that can protect against uveitis

Researchers find unique cell type that can protect against uveitis

Researchers at the National Eye Institute (NEI) have found a unique cell type that, in tests on mice, can protect against uveitis—a group of inflammatory diseases that affect the eye and can cause vision loss. [More]
BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

BioLight enrolls first patient in FDA Phase 1/2a clinical trial with Eye-D for treatment of glaucoma

BioLight Israeli Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces that the first patient has been enrolled in the U.S. into a FDA Phase 1/2a clinical trial with Eye-D, the company's controlled-release latanoprost insert for the treatment of glaucoma. [More]
Study links nearsightedness to higher education and years spent in school

Study links nearsightedness to higher education and years spent in school

German researchers have found strong evidence that attaining a higher level of education and spending more years in school are two factors associated with a greater prevalence and severity of nearsightedness, or myopia. [More]

Aerie Pharmaceuticals' Roclatan meets all clinical endpoints in Phase 2b trial

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today reported the successful results of its Phase 2b trial for once-daily, quadruple-action RoclatanTM, a combination of Aerie's triple-action RhopressaTM with latanoprost, a prostaglandin analogue (PGA). [More]
University Hospitals introduces surgical procedure for management of glaucoma in NE Ohio

University Hospitals introduces surgical procedure for management of glaucoma in NE Ohio

With the arrival of a leading expert in glaucoma, Douglas Rhee, MD, as its chairman of the Department of Ophthalmology and Visual Sciences, University Hospitals Case Medical Center is introducing a surgical procedure for the management of glaucoma that is new to Northeast Ohio. [More]

Low-power sensor to track changes in eye pressure for management of glaucoma

Your eye could someday house its own high-tech information center, tracking important changes and letting you know when it's time to see an eye doctor. [More]
Bayer HealthCare seeks EU marketing authorization of EYLEA for macular edema following BRVO

Bayer HealthCare seeks EU marketing authorization of EYLEA for macular edema following BRVO

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO). [More]
UAB ophthalmologists offer tips to prevent firework related injuries

UAB ophthalmologists offer tips to prevent firework related injuries

Fourth of July 2013: Family members were shooting fireworks in the backyard of Dianne Peterson's home in Vincent, Alabama, as she walked out of the house. [More]
CenterVue's next generation Macular Integrity Assessment receives FDA clearance

CenterVue's next generation Macular Integrity Assessment receives FDA clearance

CenterVue, Inc., a leader in the design and manufacture of highly automated medical devices for the diagnosis and management of ocular pathologies, today announced FDA 510(k) clearance has been granted for the company's next generation Macular Integrity Assessment (MAIA). [More]

Rand Eye Institute's hurricane eye safety tips

In response to the rising number of hurricane related injuries over the past hurricane seasons, the Rand Eye Institute, a comprehensive eye care and surgical facility in Deerfield Beach, is assisting South Florida residents anticipate and prepare for an increasing number of storm related eye injuries. [More]
IRIDEX’ Micropulse technology safe, durable for treating glaucoma

IRIDEX’ Micropulse technology safe, durable for treating glaucoma

IRIDEX Corporation (Nasdaq: IRIX) today announced that data from a one-year, multi-center study demonstrates the safety and durability of its proprietary MicroPulse technology as a treatment for glaucoma. [More]

Leica Microsystems and Med X Change announce select Leica surgical microscopes are now available with integrated 1080p recording

Leica Microsystems and Med X Change announce that select Leica surgical microscopes are now available with integrated 1080p video recording and still image capture. The compact Med X Change EvolutionHD 2D Medical Video Recorder, EVO for short, seamlessly integrates with the microscope stands, providing high definition video recording without interrupting surgical workflow. This small, powerful, high end medical video recorder with state-of-the-art features delivers surgical content automatically to Apple® iPad and iPhone mobile devices. Leica Microsystems presented the system at the American Society of Cataract and Refractive Surgery / American Society of Ophthalmic Administrators Symposium & Congress, April 25-29, 2014, in Boston, MA, USA. [More]
Optegra top tips for healthy eyes this hayfever season

Optegra top tips for healthy eyes this hayfever season

This year's hayfever season is upon us: the temperatures and pollen count start to rise, noses are beginning to run and eyes are starting to itch. [More]

Eleven Biotherapeutics reports financial results and operational highlights for Q1 2014

Eleven Biotherapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014. [More]
PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex revenues decrease 12% to $50.1 million in first quarter 2014

PhotoMedex, Inc. reports financial results for the three months ended March 31, 2014 and announces LCA-Vision stockholder approval of PhotoMedex's previously announced acquisition of all outstanding shares of LCA-Vision, a leading provider of laser vision correction services under the LasikPlus brand. [More]